News
GRDN
33.87
-0.65%
-0.22
Weekly Report: what happened at GRDN last week (0309-0313)?
Weekly Report · 2d ago
Mid-Cap healthcare stocks ranked by quant ratings after earnings season
Seeking Alpha · 3d ago
Guardian Pharmacy Services (GRDN) Profitability Turn Reinforces Bullish Margin Narratives
Simply Wall St · 5d ago
Guardian Pharmacy Svcs Is Maintained at Outperform by Oppenheimer
Dow Jones · 5d ago
Oppenheimer Maintains Outperform on Guardian Pharmacy Service, Raises Price Target to $38
Benzinga · 5d ago
Guardian Pharmacy Svcs Is Maintained at Buy by Truist Securities
Dow Jones · 5d ago
Guardian Pharmacy Svcs Price Target Raised to $38.00/Share From $34.00 by Truist Securities
Dow Jones · 5d ago
Truist Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $38
Benzinga · 5d ago
Guardian Pharmacy price target raised to $38 from $35 at Oppenheimer
TipRanks · 6d ago
Guardian Pharmacy price target raised to $38 from $34 at Truist
TipRanks · 6d ago
Guardian Pharmacy Services Posts Strong Growth Amid Headwinds
TipRanks · 6d ago
Guardian Pharmacy Services raises 2026 adjusted EBITDA guidance to $120M–$124M amid IRA transition and strong cash flow
Seeking Alpha · 6d ago
Guardian Pharmacy (GRDN) Earnings Transcript
The Motley Fool · 6d ago
I'm happy to help! However, I don't see any article text provided. The text you provided appears to be the table of contents for a 10-K financial report, which is a lengthy document that companies file with the Securities and Exchange Commission (SEC). If you could provide the actual article text, I'd be happy to help you generate a title for the article.
Press release · 6d ago
Guardian Pharmacy Services (GRDN) Surpasses Q4 Earnings and Revenue Estimates
NASDAQ · 6d ago
Guardian Pharmacy Services GAAP EPS of $0.37 beats by $0.15, revenue of $397.6M beats by $7.56M
Seeking Alpha · 6d ago
Guardian Pharmacy reports Q4 EPS 37c, consensus 27c
TipRanks · 6d ago
Guardian Pharmacy backs FY26 revenue view of $1.40B-$1.42B, consensus $1.42B
TipRanks · 6d ago
*Guardian Pharmacy Svcs Raises 2026 Adjusted Ebitda View to $120M-$124M From $115M-$118M >GRDN
Dow Jones · 6d ago
*Guardian Pharmacy Svcs 4Q Adj EPS 37c >GRDN
Dow Jones · 6d ago
More
Webull provides a variety of real-time GRDN stock news. You can receive the latest news about Guardian Pharmacy Services, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About GRDN
Guardian Pharmacy Services, Inc. is a long-term care pharmacy services company. Through its locally based business model, it partners with long-term care facilities (LTCF0073) to deliver medications, and a comprehensive suite of technology-enabled services designed to enhance care and improve adherence to drug regimens, helping to reduce the cost of care and improve clinical outcomes. Through its locally based pharmacies, the Company utilizes a complex, technology-enabled platform to manage the dispensing and administration of prescriptions to residents of LTCFs over the full prescription lifecycle in order to manage medication risk. Its Guardian Compass platform offers insights to enhance efficiency for its pharmacies, including proprietary real-time operational dashboards and metrics. Its suite of GuardianShield products offers customer and clinical services that benefit both the residents it serves and their caregivers.